Evidence map›Paper›PMID 41726253›Full record

ArticleIndustrial & engineering chemistry research2025

Self-Assembly of

Lauren E Eccles, Andrea A Orozco, Rebecca K Liwang, Whitney L Stoppel

Abstract read
In one paragraph

Article in Industrial & engineering chemistry research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lauren E EcclesChemical Engineering, University of Florida, Gainesville FL, 32611, USA.
Andrea A OrozcoChemistry, University of Florida, Gainesville FL, 32611, USA.
Rebecca K LiwangBiology, University of Florida, Gainesville FL, 32611, USA.
Whitney L StoppelChemical Engineering, University of Florida, Gainesville FL, 32611, USA.

Funding

Leveraging biodiversity and utilizing genetic engineering to expand the structure and function of silk fibroin biopolymers for biomedical applicationsR35GM147041 · NIGMS · UNIVERSITY OF FLORIDA · PI Whitney L Stoppel · 2022 to 2026
$1.9M
NIGMS NIH HHS R35 GM147041
6 · The paper itself

Abstract

Silk proteins represent a unique class of biopolymers produced by arthropods that can be leveraged to form a wide range of biomaterials, including particles at the nano- and micro-scale. Silk-derived particles are stable, biodegradable into amino acids, and can entrap and stabilize cargo for applications in healthcare, agriculture, and advanced materials. The utility of silk particles stems from their inherent protein folding, leading to crystalline domains that kinetically trap and stabilize cargoes. Organization and presence of these domains is dependent on synthesis methodology, protein composition (silk fibroin, silk sericin, silk composites), and encapsulated cargo molecules. Herein, we evaluate regenerated silk particles derived from

Indexed as

biopolymernanoprecipitationparticlesphase separationsilk

Identifiers

PMID41726253
PMCPMC12922628

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.